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Abstract
Background Management of fibrous dysplasia of the
proximal femur is a progressive, often recurrent condition
of bone that can cause skeletal deformity, fractures, and
pain. Allogeneic cortical strut grafting to minimize the risk
of fracture or as part of fracture treatment is a promising
treatment option, but evidence is scarce on the intermedi-
ate- to long-term results of this procedure and there are no
data on factors associated with graft failure.
Questions/purposes The purposes of this study were (1)
to evaluate the revision-free survivorship; (2) radiographic
findings; (3) factors associated with failure; and (4) com-
plications associated with cortical strut allograft to prevent
or treat fractures of the proximal femur in patients with
fibrous dysplasia.
Methods Between 1980 and 2013 we performed cortical
strut allografting in 30 patients for impending or actual
fractures of the proximal femur, of whom 28 (93%) were
available for followup at a minimum of 2 years (mean, 13
years; range, 4–37 years) and of whom 22 (73%) had also
been evaluated within the last 5 years. During that time, the
indications for cortical strut allografting were an impend-
ing fracture of the proximal femur, persistent pain, or an
actual nondisplaced femoral fracture. In patients who pre-
sented with a diaphyseal fracture, a fracture with severe
dislocation of severe varus deformity, which required an
osteotomy, placement of a blade plate was instead per-
formed and these patients are not included here. During
that time, for patients with diaphyseal fractures, and in
patients with a displaced femoral fracture of the proximal
femur, placement of a blade plate without strut grafting
was instead performed; these patients are not included here.
The primary outcome was the success rate of allogeneic
cortical strut grafting surgery as assessed by the absence of
revision surgery for a newly sustained fracture, resorption
of the graft, or progressive deformity of the proximal
femur. The association of possible contributing factors to
graft failure such as gender, age at surgery, preoperative
fracture, and anchoring distances of the graft in healthy
bone was also evaluated using Cox regression analysis.
Results Revision surgery was performed in 13 patients,
resulting in a mean survival time of 13 years (Kaplan-
Meier 95% confidence interval [CI], 10–16). Radiological
resorption of the graft was observed in 15 of 28 patients
(54%). However, revision surgery was not performed in all
patients who developed graft resorption, because of the
absence of a risk for fracture on the basis of the anatomical
site of resorption. Identified risk factors for graft failure
included preoperative fractures (hazard ratio [HR], 4.5;
95% CI, 1.2–17.2; p = 0.028) and insufficient proximal
anchoring of the graft in healthy bone (HR, 6.02; 95% CI,
1.3–27; p = 0.02). One patient sustained a refracture after
surgery resulting from an in-hospital fall. The fracture was
treated without further surgery, and it healed.
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Conclusions Our findings from this study suggest that
cortical strut allografting may be a viable option for
treatment of fibrous dysplasia of the proximal femur a
without previous pathological fracture. Surgeons should
pay particular attention to the proximal fixation point of the
allograft to decrease the risk of failure. Patients with a
fracture have an increased risk of failure and reoperation
and so should be treated with an osteosynthesis.
Level of Evidence Level IV, therapeutic study.
Introduction
Fibrous dysplasia (fibrous dysplasia) is a rare benign bone
disease caused by a postzygotic, activating mutation of the
GNAS gene, which alters the signaling of G-protein at the
cellular level. The bone lesions are characterized by local
replacement of healthy bone by fibrous tissue, which is
produced by poorly differentiated osteoblasts, osteoclast
activation, and local increase in bone turnover. Clinical
manifestations include pain, deformities, and increased risk
for fractures. The spectrum of fibrous dysplasia includes
single lesions (monostotic fibrous dysplasia), multiple
lesions (polyostotic fibrous dysplasia), and the combination
of polyostotic disease with extraskeletal manifestations
such as precocious puberty, hormonal dysregulation, and
cafe´-au-lait skin patches as observed in McCune-Albright
syndrome. Although lesions may occur in any bone, the
proximal femur and craniofacial bones are the predominant
localizations of fibrous dysplasia [3]. As a result of the
weightbearing properties of the proximal femur, lesions at
this site are vulnerable to microfractures, which may be
associated with pain, pathological fractures, and ultimately
a varus deformity of the femoral neck, leading to the
‘‘shepherd’s crook deformity’’ characteristic of fibrous
dysplasia lesions at this site.
Lesions of the proximal femur historically have been
treated with curettage and cancellous bone grafting [10].
However, these procedures were associated with a high risk
of local recurrence, and the use of cortical grafts subse-
quently was proposed as a preferable alternative on the
basis that cortical bone may be less prone to replacement
by dysplastic tissue [7, 9]. In 2005 DiCaprio and Enneking
[6] suggested that allogeneic cortical strut grafting should
be used instead of autogenous cortical bone in fibrous
dysplasia because they would be less likely or at least
slower to be replaced by dysplastic tissue, therefore pro-
viding better material for grafting.
Whereas failure rates were reported to be lower in
allogeneic cortical strut grafting compared with cancellous
bone grafting, it has so far been difficult to anticipate which
patients are more likely to benefit from allogeneic cortical
strut grafting and which factors are associated with graft
failure [6, 10]. In addition, to our knowledge, there are few
reports on long-term followup of patients treated with
cortical strut allografting; because fibrous dysplasia has a
propensity to recur, this is an important gap in knowledge.
We therefore sought (1) to evaluate the revision-free
survivorship; (2) radiographic findings; (3) factors associ-
ated with failure; and (4) complications associated with
cortical strut allograft to prevent or treat fractures of the
proximal femur in patients with fibrous dysplasia.
Patients and Methods
Data on all patients who received an allogeneic cortical
strut graft for fibrous dysplasia of the proximal femur from
1980 to 2013 at the Orthopaedic Department of the Leiden
University Medical Center were evaluated in a retrospec-
tive study design. In The Netherlands, this kind of research
does not need approval of the ethical committee.
Patient Population
Between 1980 and 2013 we performed cortical strut allo-
grafting in 34 patients for impending or actual fractures of
the proximal femur or for persistent pain nonresponsive to
medical treatment. Patients who underwent additional
valgus osteotomy (n = 4) were excluded from the study,
because the aim of our study was to evaluate the efficacy of
allogeneic cortical strut grafting in preventing varus
deformity rather than to correcting it. Another two patients
were excluded because followup was below the minimum
of 2 years. This left 28 patients (82%) available for fol-
lowup at a minimum of 2 years (mean, 13 years; range, 4–
37 years), of whom 22 (73%) had also been evaluated
within the last 5 years.
Sixteen of the 28 patients studied (57%) had monostotic
disease, 11 (39%) had polyostotic disease, and one patient
had McCune-Albright syndrome (Table 1). Gender was
evenly distributed (15 female, 13 male). Median age at the
time of allogeneic cortical strut grafting was 23 years
(range, 5–50 years), and mean followup after surgery was
13 years (range, 4–37 years). Four patients had surgery of
the proximal femur before allogeneic cortical strut graft
surgery and 11 patients had a preoperative fracture (for
details, see Table 1). Of the 28 patients who were treated
with allogeneic cortical strut grafting, 27 received a fibular
strut graft and one patient received a tibial strut graft
(seven dual struts and 21 single). Twenty-one patients were
additionally treated with curettage and placement of allo-
geneic cancellous bone during the allogeneic cortical strut
grafting procedure.
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Treatment Algorithm
The indications (Fig. 1) for cortical strut allografting dur-
ing the followup period were agreed on by all participating
surgeons. They included impending fracture of the proxi-
mal femur, persistent pain, or an actual nondisplaced
femoral fracture. During that time, for patients with dia-
physeal fractures, patients who were treated with an
osteotomy and in patients with a displaced fracture of the
proximal femur, placement of a blade plate without strut
grafting were instead performed (nine patients); these
patients are not included in the current study. Curettage in
combination with cancellous bone grafting was performed
occasionally (five patients) in individuals presenting with
pain but with a small, circumscribed lesion and whose
images did not suggest a risk of pathological fracture;
likewise, those patients are not included in this study.
Allogeneic Cortical Strut Grafting Technique
The patient was placed in a supine position and a straight
lateral incision was made to expose the greater trochanter
and diaphysis; the femur was reached posteriorly to the
vastus lateralis. A Kirschner wire was introduced in the
fibrous dysplasia lesion under guidance of fluoroscopy by
passing it through the lateral cortical bone at the level of
the lesser trochanter, pushing it through the fibrous dys-
plasia lesion to the end in the femoral head, specifically
aiming for the tip of the Kirschner wire ending in vital
cancellous bone while evading the physis if still open. A
cannulated reamer was then placed over the Kirschner
wire to create a fitting tunnel for the allogeneic cortical
strut grafting. Material was obtained from the lesion if
biopsy had not been performed before the procedure.
Curettage of the defect was not routinely performed but
particularly in cases with scalloping and thinning of the
cortex in which case it was necessary to partially fill the
lesion with cancellous bone graft. The diameter of the
strut graft was compared with the drilled tunnel to secure
smooth insertion of the allogeneic cortical strut grafting.
Under fluoroscopy a Kirschner wire was introduced into
the center of the allogeneic cortical strut grafting for more
accurate docking. The cortical allograft was then placed
over the Kirschner wire and the lateral protruding graft
was leveled with the femoral cortex. An additional allo-
geneic cortical strut graft was inserted in lesions that
involved more than three-fourths the diameter of the
femoral neck.
Patients were encouraged to mobilize postoperatively
using two crutches and partial weightbearing (up to a
maximum of 15 kg). Gradual increase in weightbearing
was allowed after 6 weeks if increasing consolidation of
the graft was observed on plain radiographs.
Outcomes Assessment
The primary outcome of our study was the proportion of
patients undergoing revision surgery as a result of fracture,
progressive deformity, and/or progressive resorption of the
graft with return of pain.
Fig. 1 The protocol for surgical treatment of fibrous dysplasia of the proximal femur in our center is shown.
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Resorption of the graft was determined by evaluation of
consecutive, yearly radiographs undertaken by one of the
authors (BCJM). Grafts were scored as ‘‘totally resorbed’’
if over 50% of the graft was resorbed or if resorption
extended to the full diameter of the graft.
Potential risk factors for revision surgery were also as-
sessed, including gender, age at the time of surgery, a
preoperative fracture, proximal and distal anchoring of the
graft in healthy bone, concurrent curettage of the fibrous
dysplasia lesion during allogeneic cortical strut grafting
surgery, and concurrent placement of cancellous bone
during allogeneic cortical strut grafting surgery. Proximal
and distal anchoring was assessed by measuring the length
of both the proximal and distal parts of the graft that were
anchored in vital bone (Pa and Da in Fig. 2) and the length
of the femoral neck (LFC in Fig. 2). We then calculated the
ratio of the proximal and of the distal length of the graft in
vital bone to the length of the femoral neck. The ratio had
to be used because old radiographs were used without
calibrated measuring options.
Statistical Analysis
Statistical analysis was performed with the use of SPSS for
Windows, Version 23.0 (SPSS, Inc, Chicago, IL, USA).
Survival analysis was performed with the use of the
Kaplan-Meier method. Risk factors were assessed with use
of the log-rank test and/or with a univariate Cox regression
model and results are presented as mean ± SD. The
influence of continuous data, for example age at the time of




Overall revision-free survival was 54% after 20 years and
mean survival time in Kaplan-Meier (Fig. 3) was 13 years
(95% confidence interval [CI], 10–16). Thirteen of 28
patients (46%) underwent a reoperation as a result of
resorption of the graft (61%), a fracture (31%), or as a
result of progressive deformation of the proximal femur
(8%). Mean time to graft failure was 7 ± 8 years.
Radiological Appearance of Grafts
Radiological resorption of the graft (Fig. 4) was observed
in 15 patients (54%). However, revision surgery was not
performed in all patients who developed graft resorption,
because according to the treatment protocol in our center,
surgery is only required in case of an impending or actual
fracture and/or persistent pain. The other 13 patients
showed full incorporation of the bone graft (Fig. 5).
Factors Associated With Survivorship of Grafts
Preoperative fracture was associated with increased risk for
revision surgery (hazard ratio [HR], 4.5; 95% CI, 1.2–17.2;
p = 0.028; Table 2) as was insufficient proximal anchoring
of the graft in vital bone (HR, 6.0; 95% CI, 1.3–27.0; p =
0.020), although this was not the case for insufficient distal
anchoring (HR, 1.4; 95% CI, 0.5–4.2; p = 0.543) with the
numbers available. Revision-free survival curves of the risk
factors confirmed the results of the Cox regression analysis
(Fig. 3). Gender, type of fibrous dysplasia, additional
curettage and/or cancellous bone grafting, and previous
surgery before allogeneic cortical strut graft surgery did not
appear to be associated with reoperation after allogeneic
cortical strut graft surgery with the numbers available.
Although patients who received cortical allografts at a
young age appeared to have an increased risk of reopera-
tion compared with older patients, age was not associated
with revision surgery (HR, 1.05/year; 95% CI, 1.0–1.1; p =
0.087).
Fig. 2 Assessment of the anchoring ratio of the graft in vital bone.
The proximal anchoring (Pa) and distal anchoring (Da) parts of the
graft were measured and divided by the length of the femoral collum
(LFC) to obtain the ratio. In case two grafts were used, we chose the
measurement with the deepest anchoring. LFC was defined by as the
length between the lateral cortex and femoral head in alignment with
the graft.
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Complications
One patient sustained a refracture after surgery resulting
from an in-hospital fall. The fracture was treated without
further surgery, and it healed. No other complications of
surgery were observed.
Discussion
Despite progress in understanding the pathogenesis of
fibrous dysplasia, its treatment has been subject to con-
troversy ever since the first reports of Lichtenstein on
management of the disease, emphasizing its notorious
recurrent character, the wide variations in phenotype, and
the lack of a successful treatment strategy [15, 16]. Over
the past few decades many surgical approaches have been
proposed and discarded in the management of fibrous
dysplasia ranging from particular forms of grafting to a
variety of types of implants or a combination of both [6].
Although curettage and bone grafting using cancellous
bone have been historically the treatments of choice, the
perspective of the value of this treatment in fibrous dys-
plasia lesions of the proximal femur has altered over the
last decades as a result of increasing reports on the mar-
ginal outcome of the procedure (Table 3) [10–12, 18, 19,
Fig. 3A–C The Kaplan-Meier curve for revision-free survival (A) indicates that most failures occur in the first 5 years after surgery. The Kaplan-
Meier curves (B–C) illustrate the role of a preoperative fracture and insufficient proximal anchoring on revision-free survival.
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23]. We theorized that allogeneic cortical strut grafting
might improve the outcome of fibrous dysplasia lesions of
the proximal femur, arguing that cortical allografts would
be less prone to be affected by pathological fibrous dys-
plasia bone and therefore less prone to resorb and fail. We
found that allogeneic cortical strut grafting has a sur-
vivorship of 54% after long-term followup and that patients
who presented with fracture (as opposed to impending
fracture) and patients whose grafts lacked sufficient prox-
imal fixation were at increased risk of undergoing
reoperation.
This study had a number of limitations. First, the small
number of patients included in our study reflects the low
prevalence of symptomatic fibrous dysplasia, although our
series of patients was larger than any reported thus far of
which we are aware. Because of a small study size, it is
possible that we were unable to detect the less common
complications of allogeneic cortical bone grafting. Fur-
thermore, we have to take into account the possibility that
some of the risk factors that were not associated with
treatment outcome in our study might show an association
in larger studies. Second, the long span of time over which
this retrospective study’s procedures were performed saw
many changes in patient care. Although the indications
were generally consistent over time at the study site, it is
impossible to know with certainty that they were applied
with precision over the nearly 35-year timeframe. Also,
many of these procedures were performed before patient-
reported outcomes tools came into wide use, and so we
could not report patient-reported outcomes here. It is our
impression based on chart review and patient surveys done
after surgery that pain improved in most of these patients.
Furthermore, we appreciate that the variability in treatment
options for fibrous dysplasia of the proximal femur, which
is no doubt the result of the heterogeneity of the disease,
makes it difficult to compare different patients. Although
the use of multiple trajectories, additional cancellous bone
grafting, and additional curettage were taken into account
in our analysis, these different approaches within the
treatment with cortical allografts might affect the outcome
in larger studies. Finally, although the treatment of fibrous
dysplasia is centralized in The Netherlands, it is common
in long-term studies that some patients were lost to
followup.
Although a large proportion of patients in this study
(nearly half of them) underwent revision at some point
Fig. 4A–C The radiograph (A) is made postoperatively and shows
two fibular strut grafts that cross the dysplastic lesion but have
minimal contact with vital bone proximally. After 1 year, resorption
of the graft gradually increased (B) and finally the strut graft is
resorbed over the full length of the diameter (C), losing its stabilizing
function.
b
792 Majoor et al. Clinical Orthopaedics and Related Research1
123
during the followup period, we consider the fact that more
than half of the patients did not undergo further surgery
actually a reasonably good result. The reason for this is that
the condition recurs so commonly, and other described
approaches actually reported even more frequent failures
than we observed here [10, 23]. Most previous studies were
restricted to limited followup and are therefore likely to
overestimate the therapeutic effect of bone grafting, a fact
that is further emphasized by studies with long-term fol-
lowup generally, suggesting a poorer outcome (Table 3).
Because of its mean followup of 13 years, our study gives a
fair representation of the long-term effects of allogeneic
cortical strut graft treatment in fibrous dysplasia lesions of
the proximal femur. However, Kaplan-Meier survivorship
analysis (Fig. 3A) showed that most reoperations were
performed within 5 years after the primary surgery, indi-
cating that after 5 years, failure of allogenous cortical strut
grafts leading to reoperation is less likely to be expected. In
addition, besides being biologically preferable to prevent
graft resorption, the use of allogeneic bone has the
advantage of no additional surgery being required to
retrieve autogenous bone.
Slightly more than half of our patients experienced
radiographic evidence of graft resorption. Again, however,
we consider this a reasonably good result considering the
problems reported using other techniques when dealing
with proximal femoral lesions in patients with fibrous
dysplasia, especially in studies addressing cancellous bone
grafting in which recurrence is reported in nearly all
patients [10, 23]. Although the indication for reoperation
was graft resorption in the majority of the cases (61%),
graft resorption was not an indication for reoperation per
se, because we would only perform a reoperation in case
graft resorption led to an impending or an actual fracture.
We identified several risk factors for failure of allo-
geneic cortical strut graft surgery in this study. In patients
undergoing cortical strut allografting, we found a minimal
proximal anchoring ratio in vital bone of 5% is required to
enable the graft to be incorporated in the proximal femur.
Therefore, proper evaluation of proximal placement pre-
operatively and intraoperatively should be mandatory,
whereas this is not so for distal anchoring in which case
anchoring in the cortex will generally suffice. Although it
has previously been reported that insufficient proximal
Fig. 5A–C The radiograph of Patient 17 shows an expansive lesion in
the proximal femur with a ground glass aspect and cortical thinning
(A). The diagnosis of fibrous dysplasia was histologically confirmed
and the patient was treated with implantation of two fibular strut
grafts (B). The strut grafts gradually incorporated in vital bone and
the radiograph showed a stable situation 7 years after surgery. (C) The
patient could be discharged from further controls with good function
and no pain.
b
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docking in healthy bone might have played a role in failure
of allogeneic cortical strut grafting in two patients in the
Enneking/Gearen study [7], our study is the first to clearly
identify insufficient proximal anchoring of the graft and
preoperative fractures as risk factors for failure of allo-
geneic cortical strut graft surgery.
Our data also demonstrate a higher risk of revision in
patients with a preoperative fracture. Patients who sus-
tained a fracture of the proximal femur at some point
before surgery have thus a high risk of failure of allogeneic
cortical strut grafting by either resorption or a consecutive
fracture. We suspect that a pathological fracture is only the
endpoint of a sliding scale. Guille et al. already identified
involvement of the calcar femorale as a risk factor for
failure [10]. If the calcar is involved, the proximal femur
will considerably lose stability by loss of redistribution of
stress forces [26]. Subsequently the proximal femur will be
more prone to fractures. A cortical strut graft will very
likely not be able to address the extensive forces applied on
the proximal femur without this form of stability. Based on
the results with internal fixation in other studies [1, 4, 5, 8,
10, 12–14, 17, 20, 23–25] and the findings from our present
study, we recommend primary internal fixation in patients
with extensive lesions that threaten to fracture or have
already induced a fracture, because this approach has
shown promising results in several studies. More impor-
tantly, although only the combination of internal fixation
and autografts has so far been studied, there might be an
important role for implantations in combination with cor-
tical allografts in patients with preoperative risk factors.
Although the polyostotic form of fibrous dysplasia is
generally associated with a worse outcome compared with
monostotic disease [6, 10], we were not able to identify
polyostotic fibrous dysplasia as a risk factor for graft fail-
ure. This may be explained by the fact that polyostotic
fibrous dysplasia can be profoundly variable in its course
and in the extent of lesions. Patients with extensive lesions,
both monostotic and polyostotic fibrous dysplasia, were
primarily treated with internal fixation, because a strut graft
would not properly bridge the lesion and therefore local
expansion and not the type of fibrous dysplasia would be a
risk factor. Furthermore, we expected that young age at the
time of surgery would be a risk factor based on the
hypothesis that fibrous dysplasia tends to be more active
and aggressive during childhood and because patients with
extensive disease are generally diagnosed at a younger age
[22]. However, we were unable to demonstrate this in the
present study, perhaps because of the statistical limitations
imposed on our statistical analysis by the sample size.
Although this procedure can be technically challenging,
we were gratified by the relative rarity of complications in
this series. This compares favorably to bone grafting with
autogenous bone, which can be accompanied by compli-
cations at the donor site [2, 21].
Table 3. Previous studies into surgical treatment of fibrous dysplasia of the femoral neck





Harris et al. (1962) [11] 10 Cancellous autograft Unknown 5/10 Five of 10 had a poor outcome
Nakashima et al. (1984) [18] 8 Autograft Unknown 2/8 25% had a poor outcome
Enneking and Gearen (1986) [7] 15 Cortical autograft 6 years 2/15 Two of 15 had a poor outcome (reoperation)
Stephenson et al. (1987) [23] 18 Cancellous autograft 10.4 years 25/31 81% had a poor outcome
Guille et al. (1998) [10] 22 Cancellous autograft 15 years 22/22 100% had resorption
Ippolito et al. (2003) [12] 5 Cancellous autograft Unknown 3/5 Three of 5 patients had a poor outcome
(reoperation)
George et al. (2008) [9] 8 Cortical autografts 4.1 years 1/8 One patient had a poor outcome (recurrence).
Tong et al. (2013) [24] 15 Cancellous autograft with
internal fixation
12–32 months 0/15 No patients needed a reoperation
Nishida et al. (2015) [19] 8 Cortical autograft with
internal fixation
75 months 0/8 No patient had a poor outcome







Monostotic fibrous dysplasia 0.50 0.2–1.6 0.230
Previous surgery 0.79 0.2–3.6 0.756
Additional curettage + CBG 1.34 0.4–4.9 0.657
Distal anchoring ratio B 5% 1.40 0.5–4.2 0.543
Gender (male) 1.40 0.5–4.2 0.543
Preoperative fracture 4.50 1.2–17.2 0.028
Proximal anchoring ratio B 5% 6.02 1.3–27.0 0.020
Age at surgery 1.05/
year
1.0–1.1 0.087
ACSG = allogeneic cortical strut graft; CBG = cancellous bone
grafting.
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Our findings from this study suggest that cortical strut
allografting may be a viable option for treatment of fibrous
dysplasia of the proximal femur who have not already
experienced a fracture. Surgeons should pay particular
attention to the proximal fixation point of the allograft to
decrease the risk of failure. Patients with a fracture have an
increased risk of failure and reoperation and so should be
treated with osteosynthesis.
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